Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Liu

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Neuro-Oncology Advances|February 4, 2026
Metabolomic profiling and stable isotope tracing of human schwannomas: A novel perspective on tumor biology and radiation responseMark C Dougherty, Hashim S Syed, Linjing Xu, et al.
JAAD International|January 6, 2022
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysisNorito Katoh, Yukihiro Ohya, Hiroyuki Murota, et al.
Dermatology and Therapy|November 19, 2022
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up StudyNorito Katoh, Yukihiro Ohya, Hiroyuki Murota, et al.
Journal of Neurosurgery|November 29, 2024
The value of a neurosurgeon: is neurosurgical compensation proportional to value added? A systematic review of the literature and an update on a changing healthcare economyBenjamin S Hopkins, Jonathan Dallas, Gage Guerra, et al.
Advances in Therapy|January 3, 2024
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled TrialsEduardo Mysler, Gerd R Burmester, Christopher D Saffore, et al.
Metabolic Syndrome and Related Disorders|December 11, 2013
Mitochondrial uncoupling protein 2 induces cell cycle arrest and necrotic cell deathArun P Palanisamy, Gang Cheng, Alton G Sutter, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
<i>Eed</i> controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crestTim Casey-Clyde, S John Liu, Juan Antonio Camara Serrano, et al.
Seminars in Ophthalmology|August 28, 2025
Differential Sex-Based Enrolment into US-Registered Glaucoma Clinical Trials: A Cross-Sectional StudyBrendan K Tao, Jim S Xie, Anastasiya Vinokurtseva, et al.
Journal of the American Academy of Dermatology|June 17, 2022
Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trialsPedro Mendes-Bastos, Barry Ladizinski, Emma Guttman-Yassky, et al.
World Neurosurgery|October 24, 2021
Disparities in the Surgical Treatment of Adult Spine Diseases: A Systematic ReviewTyler Cardinal, Phillip A Bonney, Ben A Strickland, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Neuro-Oncology Advances|February 4, 2026
Metabolomic profiling and stable isotope tracing of human schwannomas: A novel perspective on tumor biology and radiation responseMark C Dougherty, Hashim S Syed, Linjing Xu, et al.
JAAD International|January 6, 2022
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysisNorito Katoh, Yukihiro Ohya, Hiroyuki Murota, et al.
Dermatology and Therapy|November 19, 2022
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up StudyNorito Katoh, Yukihiro Ohya, Hiroyuki Murota, et al.
Journal of Neurosurgery|November 29, 2024
The value of a neurosurgeon: is neurosurgical compensation proportional to value added? A systematic review of the literature and an update on a changing healthcare economyBenjamin S Hopkins, Jonathan Dallas, Gage Guerra, et al.
Advances in Therapy|January 3, 2024
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled TrialsEduardo Mysler, Gerd R Burmester, Christopher D Saffore, et al.
Metabolic Syndrome and Related Disorders|December 11, 2013
Mitochondrial uncoupling protein 2 induces cell cycle arrest and necrotic cell deathArun P Palanisamy, Gang Cheng, Alton G Sutter, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
<i>Eed</i> controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crestTim Casey-Clyde, S John Liu, Juan Antonio Camara Serrano, et al.
Seminars in Ophthalmology|August 28, 2025
Differential Sex-Based Enrolment into US-Registered Glaucoma Clinical Trials: A Cross-Sectional StudyBrendan K Tao, Jim S Xie, Anastasiya Vinokurtseva, et al.
Journal of the American Academy of Dermatology|June 17, 2022
Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trialsPedro Mendes-Bastos, Barry Ladizinski, Emma Guttman-Yassky, et al.
World Neurosurgery|October 24, 2021
Disparities in the Surgical Treatment of Adult Spine Diseases: A Systematic ReviewTyler Cardinal, Phillip A Bonney, Ben A Strickland, et al.
Pageof 15